$LLY
Eli Lilly & Co.
XNYS•Health Care•Pharmaceutical Preparations
Why is LLY down today? It is at $1253.02 (-2.13%), and our scanner flagged it 129 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LLY spikes, and full due diligence on LLY — key stats, earnings, dilution and insider activity. Free.
Get free $LLY alerts the moment volume spikes
Our scanner flagged $LLY 129 times in the last 30 days. Create a free account to track $LLY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1253.02
- Change today
- -2.13%
- Previous close
- $1280.34
- 52-week range
- $694.23 – $1292.65
- Market cap
- $1.15T
- Dividend yield
- 0.54% ($6.92)
- Institutional own.
- 94.63%
- Total held
- 94.8%
- Tradeable float
- 49.2M 5% of shares · after <1% insiders + 95% institutions
- Short interest
- 9.1M ▼ -11% vs prior · as of 2026-07-31
- Short % of float
- 18.5%
- Days to cover
- 3.9d
- Avg daily volume
- 3.3M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNYS
- 5m
- 0.2x
- 15m
- 0.9x
- 1h
- 1.3x
- 1D
- 0.1x
Get free LLY + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $LLY down today?
LLY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on LLY today, peaking at 3.0x its normal volume.
Likely catalystELI LILLY & Co: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 18, 2026 · yesterdayAnalyst data via Nasdaq. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
Insiders
Insiders buying12 buys, 5 sells last 3 months (70/60 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Jonsson Patrik Officer | Sold (automatic/other) | -7K | sold 11% | 54K | $7.6M at $1175.10 | Aug 17, 26 |
Alvarez Ralph Director | Acquired (grant/award) | +10 | added <0.1% | 56K | $12K at $1183.16 | Aug 17, 26 |
Fyrwald J Erik Director | Acquired (grant/award) | +8 | added <0.1% | 75K | $9K at $1183.16 | Aug 17, 26 |
Luciano Juan R Director | Acquired (grant/award) | +13 | added <0.1% | 17K | $15K at $1183.16 | Aug 17, 26 |
Sulzberger Gabrielle Director | Acquired (grant/award) | +4 | added 0.1% | 3K | $5K at $1183.16 | Aug 17, 26 |
Zakrowski Donald A Officer | Sold (automatic/other) | -2K | sold 57% | 2K | $2.4M at $1185.01 | Aug 10, 26 |
Hakim Anat Officer | Sold (automatic/other) | -5K | sold 15% | 28K | $6.0M at $1190.00 | Aug 7, 26 |
Seymour Melissa Officer | Sold (automatic/other) | -439 | sold 29% | 1K | $504K at $1148.84 | Aug 1, 26 |
Seymour Melissa Officer | Other | 981 | added 100% | 2K | n/a | Aug 1, 26 |
Alvarez Ralph Director | Acquired (grant/award) | +11 | added <0.1% | 56K | $13K at $1146.90 | Jul 20, 26 |
Fyrwald J Erik Director | Acquired (grant/award) | +9 | added <0.1% | 75K | $10K at $1146.90 | Jul 20, 26 |
Luciano Juan R Director | Acquired (grant/award) | +14 | added <0.1% | 17K | $16K at $1146.90 | Jul 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $LLY runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$LLY Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$LLY Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.








Stocks similar to LLY
Comparable names in pharmaceutical preparations, closest in size first.
LLY is in these themes
Curated groups LLY belongs to. Tap one to see every member with today's move and why the group is moving.
LLY stock FAQ
Why is $LLY down today?
LLY is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on LLY today, peaking at 3.0x its normal volume.
What is the LLY stock price today?
LLY last traded at $1253.02, down 2.13% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Does LLY pay a dividend?
Yes. LLY currently has a dividend yield of about 0.54% ($6.92 per share per year). Dividend figures can change; this is not investment advice.
Where can I see live LLY alerts?
The LLY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LLY 129 times in the last 30 days.
What exchange is LLY on?
LLY (Eli Lilly & Co.) trades on XNYS, with a market cap of about $1.15T in the PHARMACEUTICAL PREPARATIONS sector.
Is LLY good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LLY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.